SCHEMBL4287016

SCHEMBL4287016

O=c1[nH]c2nc(-c3c[nH]nc3Cc3cccc(F)c3)[nH]c2c(=O)n1C1CCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 12/20 0.46
ADORA1 P30542 6/20 0.46
ADORA2A P29274 5/20 0.46
ADORA3 P0DMS8 8/20 0.43
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
ADRA1B P35368 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
RGS12 O14924 1/20 0.35
NPC1 O15118 1/20 0.35
USP2 O75604 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1944947 0.78 ADORA2B (0.74) ADORA2BADORA1ADORA2AADORA3
SCHEMBL1948516 0.78 ADORA2B (0.73) ADORA2BADORA1ADORA2AADORA3
SCHEMBL1943878 0.72 ADORA2B (0.72) ADORA2BADORA1ADORA2AADORA3
SCHEMBL4293285 0.71 BRD4 (0.39) L3MBTL1CCR2
SCHEMBL5687959 0.70 ADORA2B (0.63) ADORA2BADORA1ADORA2AADORA3ALDH1A1
SCHEMBL4016371 0.70 ADORA2B (0.64) ADORA2BADORA1ADORA2AADORA3
SCHEMBL1945854 0.70 ADORA2B (0.58) ADORA2BADORA1ADORA2AADORA3
SCHEMBL4021124 0.69 AKT2 (0.38) ADORA2BADORA2AALDH1A1KDM4EMEN1
SCHEMBL2328375 0.68 ADORA2B (0.71) ADORA2BADORA1ADORA2AADORA3
SCHEMBL1947269 0.68 ADORA2B (0.69) ADORA2BADORA1ADORA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009157938-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING CANCER CV THERAPEUTICS, INC. (US) 2009-12-30 WO disclosed